Q32 Bio GAAP EPS of -$0.26 beats by $0.07

Q32 Bio beats Q3 EPS and reports $289.6M in cash to fund operations through Phase 3 bempikibart results in severe alopecia areata.

CryptoAlerta — análise de criptomoedas e mercado em tempo real